| Application no. and date | 07784350.6 (espacenet) (Federated) (European Patent Register), 20070607 | | Patent/reg. no. and date | DK/EP 2032533, 20130403 | | Publication date | 20090311 | | Priority no. and date | US 804527 P, 20060612, US 867878 P, 20061130 | | EP pub. no. and date |
EP 2032533 20090311 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | NGC/AP/147016 | | Inventor | BAJWA, Joginder, S., 50 Linwood Avenue
Elmwood Park, New Jersey 07407, US,
SLADE, Joel, 14 Theresa Drive
Flanders, New Jersey 07836, US,
ACEMOGLU, Murat, Grellingerstrasse 53
4052 Basel, CH,
PARKER, David, John, 316 Ridge Road
West Milford, New Jersey 07480, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07D 209/16 (2006.01) | | Title | Fremgangsmåde til fremstilling af N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamid samt udgangsmaterialer dertil | | Int. application no. | US2007070564 | | Int. publication no. | WO2007146718 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
